What is TRANSFORM by Prostate Cancer UK?

Prostate Cancer UK are about to execute the biggest trial in prostate cancer history

TRANSFORM is a £42 million research programme led by Prostate Cancer UK. The trial is being backed by £16 million of government funding, and will involve hundreds of thousands of people.

The objective of the trial is to ensure that those who should have a prostate examination are able to freely access one. The results of the trial will be to provide definitive evidence about the best way to screen for prostate cancer.

Why is the TRANSFORM trial needed?

Trials and initiatives are urgently needed. 12,000 men die of prostate cancer each year. It is the most common cancer in the UK without a screening programme.

Prostate Cancer usually has no symptoms until it has spread and become incurable. It is a horrible disease. The Government and the National Institute of Health and Care research have expressed a commitment to invest in better diagnosis.

The trial has been a platform for the best researchers globally and the best independent experts to come together and gain insight into prostate cancer diagnosis. With this funding and backing, Prostate Cancer UK hope to revolutionise prostate cancer awareness and national diagnosis.

To find out more about the trial see TRANSFORM by Prostate Cancer UK

A Charity Close To Our Hearts

We’ve pledged to raise £75,000 as part of a three-year partnership agreement with Prostate Cancer UK, and we’re already well ahead of schedule! But we’ve also set ourselves a target to raise £5.5 million through further fundraising activity.

See our work with Prostate Cancer UK

TRANSFORM trial by Prostate Cancer UK – further information

  • The researchers will start setting up the trial in spring 2024, and will start recruiting men to the trial later in the year.
  • The funding for this £42m programme of research will come from a variety of sources, including fundraising, reserves and high value donations.
  • The trial will test multiple promising screening methods, including MRI scans, to detect prostate cancer.
  • We have also set the researchers a target that one in ten invited to participate in the trial will be Black men between 45 and 75 years old – as they are the group with the highest risk

However, men at risk now can’t afford to wait to take action. If you’re a man over 50 – or over 45 if you are Black or have a family history of prostate cancer – please check your risk now in 30 seconds and find out what to do next with our online risk checker.